02:11 PM EDT, 03/14/2024 (MT Newswires) -- Monte Rosa Therapeutics ( GLUE ) reported Q4 net loss Thursday of $0.58 per diluted share, narrowing from the loss of $0.63 a year earlier.

Analysts polled by Capital IQ expected a loss of $0.39.

Cash and cash equivalents in the quarter ended Dec. 31 rose to $128.1 million from $54.9 million a year earlier.

The company's shares fell 7.6% in recent trading Thursday.

Price: 6.14, Change: -0.51, Percent Change: -7.59